Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162299
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-03
First Post:
2023-11-22
Brief Title:
A Phase I The Study to Evaluate the Safety Immunogenicity and Efficacy of YS-HBV-002
Sponsor:
Yisheng Biopharma Singapore Pte Ltd
Organization:
Yisheng Biopharma Singapore Pte Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Hepatitis b |
Keywords:
| Name | View |
|---|---|
| PIKA Adjuvant | View |